StockData
Bristol Myers Squibb Co logo

Bristol Myers Squibb Co (BMY) stock

BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 14/3030% below fair value
$59.56−1.79 (-2.92%)

Close on Nov 18, 2026Market cap $121.75BP/E 13.2Yield 4.18%

Bristol Myers Squibb pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Bristol Myers Squibb's pe ratio was 13.9× on Nov 11, 2026, against 16.6× a year earlier. Over the last 5 years it ranged from 11.4× to 73.7×, with a median of 18.2×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202613.9×−4.4
2025Dec 31, 202518.2×+6.8
2024Apr 30, 202411.4×−1.6
2023Dec 29, 202313.0×−10.4
2022Dec 30, 202223.4×−49.0
2020Jul 31, 202072.4×+53.8
2019Dec 31, 201918.6×−40.5
2018Dec 31, 201859.1×+34.9
2017Dec 29, 201724.1×−5.1
2016Dec 30, 201629.2×−35.7
2015Dec 31, 201564.9×+28.7
2014Dec 31, 201436.2×+4.4
2013Dec 31, 201331.8×+1.9
2012Dec 31, 201229.9×+11.6
2011Dec 30, 201118.3×–

More Bristol Myers Squibb figures

See a number that looks wrong?